Cue Health Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Cue Health is forecast to grow earnings and revenue by 51% and 38.4% per annum respectively. EPS is expected to grow by 68.7% per annum. Return on equity is forecast to be -46% in 3 years.

Anahtar bilgiler

51.0%

Kazanç büyüme oranı

68.7%

EPS büyüme oranı

Medical Equipment kazanç büyümesi17.4%
Gelir büyüme oranı38.4%
Gelecekteki özkaynak getirisi-46.0%
Analist kapsamı

Low

Son güncelleme10 Apr 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper

May 10
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper

Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%

Mar 22
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%

Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Jan 28
Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%

We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate

Jan 06
We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate

Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%

Nov 10
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%

These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat

Aug 14
These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat

Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?

Jul 12
Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?

Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)

May 15
Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)

Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%

Mar 21
Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%

We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully

Mar 12
We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully

Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price

Feb 13
Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price

Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%

Nov 18
Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%

Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation

Oct 30
Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation

Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test

Oct 04

Cue Health appoints chief medical oficer

Sep 08

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:HLTH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026207-44N/AN/A2
12/31/2025110-170N/AN/A3
12/31/202457-224N/AN/A3
12/31/202371-373-158-138N/A
9/30/2023199-257-189-161N/A
6/30/2023251-276-231-188N/A
3/31/2023329-291-255-197N/A
12/31/2022483-194-175-112N/A
9/30/2022529-138-142-51N/A
6/30/2022683-67-838N/A
3/31/202273334-4157N/A
12/31/202161833-125-9N/A
9/30/2021439-11-16134N/A
6/30/2021220-24-6076N/A
3/31/202187-37-4465N/A
12/31/202023-471593N/A
12/31/20197-21-16-13N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: HLTH is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: HLTH is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: HLTH is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: HLTH's revenue (38.4% per year) is forecast to grow faster than the US market (8.4% per year).

Yüksek Büyüme Geliri: HLTH's revenue (38.4% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: HLTH is forecast to be unprofitable in 3 years.


Büyüyen şirketleri keşfedin